These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21745224)

  • 1. The ghost in the machine: inhibition of tachyarrhythmia therapy due to phantom crosstalk.
    Ahmed J; Monahan KM; LeLorier P
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):909-11. PubMed ID: 21745224
    [No Abstract]   [Full Text] [Related]  

  • 2. Worsening heart failure as the main manifestation of neglected complete extrusion of a cardiac resynchronization therapy pacemaker.
    Vassilikos VP; Mantziari AA; Stavropoulos G; Styliadis IH
    Cardiology; 2010; 117(4):243-5. PubMed ID: 21228592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 4. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure.
    Okutucu S; Aytemir K; Evranos B; Aksoy H; Sabanov C; Karakulak UN; Kaya EB; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2011 Apr; 13(4):526-32. PubMed ID: 21076146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial.
    Durante A; Cianflone D; Camici PG
    J Am Coll Cardiol; 2011 Jul; 58(4):442-3; author reply 443-4. PubMed ID: 21757127
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.
    Romeyer-Bouchard C; Da Costa A; Dauphinot V; Messier M; Bisch L; Samuel B; Lafond P; Ricci P; Isaaz K
    Eur Heart J; 2010 Jan; 31(2):203-10. PubMed ID: 19875388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a tool combining guide-wire and stylet for the left ventricular lead positioning.
    Giannola G; Iacopino S; Lombardo E; Cesario A; Di Stefano G; Piraino LG; Campisi G; Torcivia R; Corrao D; Risi A; Denaro A; Valsecchi S;
    Europace; 2011 Feb; 13(2):244-50. PubMed ID: 21131651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iterative cardiac output measurement for optimizing cardiac resynchronization therapy: a randomized, blinded, crossover study.
    Reinsch N; Konorza T; Woydowski D; Bruck H; Volsek M; Müller-Tasch T; Neumann T; Erbel R; Wieneke H
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1188-94. PubMed ID: 20663072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing operator radiation exposure during cardiac resynchronization therapy.
    Brambilla M; Occhetta E; Ronconi M; Plebani L; Carriero A; Marino P
    Europace; 2010 Dec; 12(12):1769-73. PubMed ID: 21097481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Advantage of optimizing V-V timing in cardiac resynchronization therapy devices" by Dr. Duvall.
    Geng J; Zhu J
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1289-90; author reply 1290-1. PubMed ID: 20718923
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symptomatic tachyarrhythmia in patients with a cardiac pacemaker in emergency situations].
    Burmeister MA; Standl T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jul; 34(7):442-6. PubMed ID: 10464523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation.
    Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuss G; Zabel M
    Europace; 2010 Nov; 12(11):1574-80. PubMed ID: 20810533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 16. A tachycardia classified as supraventricular by a cardiac resynchronization therapy-defibrillator device. What is the mechanism?
    Bhargava K; Gupta N; Singh B
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):107-10. PubMed ID: 20636316
    [No Abstract]   [Full Text] [Related]  

  • 17. Pitfalls of programming sensing polarities using the coronary sinus lead in biventricular pacemakers.
    Mansour F; Arnau AM; Tolosana JM; Mont L
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):e22-5. PubMed ID: 20487348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A device to prevent heart failure is twice as effective in women.
    Harv Womens Health Watch; 2011 May; 18(9):7. PubMed ID: 21818875
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
    Ståhlberg M; Kessels R; Linde C; Braunschweig F
    Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy.
    Shetty AK; Duckett SG; Bostock J; Roy D; Ginks M; Hamid S; Rosenthal E; Razavi R; Rinaldi CA
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):484-9. PubMed ID: 21208241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.